Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
!!Link opens in a new tab
!!Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
The growth fraction of human myeloma cells
B. Drewinko
, R. Alexanian
, H. Boyer
, B. Barlogie
, S. I. Rubinow
Icahn School of Medicine at Mount Sinai
Medicine
Medicine - Hematology and Medical Oncology
Research output
:
Contribution to journal
›
Article
›
peer-review
127
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The growth fraction of human myeloma cells'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Myeloma Cells
100%
Growth Fraction
100%
Growth Kinetics
50%
Multiple Myeloma
33%
Remission
33%
Untreated Patients
33%
Plasma Cells
33%
Tumor Mass
33%
Tritiated Thymidine
33%
Unresponsive Patients
33%
Disease Stage
16%
Therapeutic Strategies
16%
Therapeutic Trial
16%
Proliferating Cells
16%
IV Infusion
16%
Biological Properties
16%
Cell Loss
16%
Transit Time
16%
Tumor Doubling Time
16%
Active Agent
16%
Labeling Index
16%
High Growth
16%
Tumor Load
16%
Prednisone Therapy
16%
Melphalan-prednisone
16%
Medicine and Dentistry
Neoplasm
100%
Myeloma Cell
100%
Multiple Myeloma
50%
Thymidine
50%
Immunoglobulin Producing Cell
50%
Cell Proliferation
25%
Biological Product
25%
Prednisone
25%
Intravenous Drug Administration
25%
Melphalan
25%
Cell Loss
25%
Diseases
25%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Myeloma
100%
Remission
50%
Multiple Myeloma
50%
Thymidine
50%
Biological Product
25%
Prednisone
25%
Melphalan
25%
Diseases
25%
Biochemistry, Genetics and Molecular Biology
Immunoglobulin Producing Cell
100%
Thymidine
100%
Cell Proliferation
50%
Melphalan
50%
Cell Loss
50%
Prednisone
50%
Neuroscience
Thymidine
100%
Immunoglobulin Producing Cell
100%
Cell Proliferation
50%
Cell Loss
50%
Prednisone
50%
Melphalan
50%